RAPT Therapeutics (RAPT) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.14
-0.87
-0.59
-0.32

Details

Expected EPS
-0.710563
Actual EPS
-0.65
Surprise EPS
0.06
Surprise Percent
+8.52%

Description

RAPT Therapeutics (RAPT) has reported earnings of -0.65 per share for Q3 2025.

0 Comments

Share your thoughts